Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director
Quarterly results
CC transcript

Larimar Therapeutics, Inc. (ZFGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 SHERMAN JEFFREY W (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 16,600 options to buy @ $3.555, valued at $59k
10/05/2023 3 SHERMAN JEFFREY W (Director) has filed a Form 3 on Larimar Therapeutics, Inc.
07/18/2023 4 Clayton Russell (Chief Medical Officer) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 180,000 options to buy @ $3.22, valued at $579.6k
07/18/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
05/18/2023 4 Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Bought 5,000 shares @ $3.7263, valued at $18.6k
05/18/2023 4 BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Bought 5,000 shares @ $3.705, valued at $18.5k
05/18/2023 4 Truitt Joseph (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Bought 2,750 shares @ $3.73, valued at $10.3k
05/11/2023 4 Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 8,300 options to buy @ $5.09, valued at $42.2k
05/11/2023 4 Truitt Joseph (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 8,300 options to buy @ $5.09, valued at $42.2k
05/11/2023 4 Hamilton Thomas Edward (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 8,300 options to buy @ $5.09, valued at $42.2k
05/11/2023 4 LEFF JONATHAN S (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 8,300 options to buy @ $5.09, valued at $42.2k
05/11/2023 4 THOMAS FRANK E (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 8,300 options to buy @ $5.09, valued at $42.2k
02/09/2023 4 Shankar Gopi (Chief Development Officer) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 180,000 options to buy @ $5.88, valued at $1.1M
02/09/2023 3 Shankar Gopi (Chief Development Officer) has filed a Form 3 on Larimar Therapeutics, Inc.
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/20/2022 4 Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Bought 2,777,777 shares @ $3.15, valued at $8.7M
09/20/2022 3 DEERFIELD PARTNERS, L.P. (10% Owner) has filed a Form 3 on Larimar Therapeutics, Inc.
09/20/2022 4 Hamilton Thomas Edward (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Bought 317,460 shares @ $3.15, valued at $1000k
09/19/2022 4 Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Bought 31,746 shares @ $3.15, valued at $100k
09/19/2022 4 BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Bought 31,746 shares @ $3.15, valued at $100k
05/12/2022 4 BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $2.92, valued at $116.8k
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 Hamilton Thomas Edward (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 8,300 options to buy @ $2.92, valued at $24.2k
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 THOMAS FRANK E (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 8,300 options to buy @ $2.92, valued at $24.2k
05/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2022 4 Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 80,000 options to buy @ $8.75, valued at $700k
01/20/2022 4 BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 182,000 options to buy @ $8.75, valued at $1.6M
07/02/2021 4 Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Bought 228,569 shares @ $8.75, valued at $2M
Bought 228,571 shares @ $8.75, valued at $2M
Bought 228,570 shares @ $8.75, valued at $2M
07/02/2021 4 Hamilton Thomas Edward (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Bought 56,710 shares @ $8.75, valued at $496.2k
05/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy